Viewing Study NCT04230759

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:53 PM
Ignite Modification Date: 2025-12-26 @ 2:29 PM
Study NCT ID: NCT04230759
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-09-19
First Post: 2020-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. a Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group
Sponsor: Goethe University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anal Cancer View
None Anal Carcinoma View
None Anal Cancer Stage III View
None Anal Cancer Stage II View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anal Cancer View
None Anal Carcinoma View
None Durvalumab View
None PD-L1 immune checkpoint inhibitor View